August 29 – September 1, 2023 | Boston, MA

The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights from discovery to commercialization.  

Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, boot camp, focus day, diversity session, C-level think tank, and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.

Join Beacon’s Cell Therapy expert, Rachel East, on conference Day 1 at 11 am, for a landscape overview of CAR & TCR therapies as part of the Translation Track, and uncover exclusive data insights from the Beacon platform. This is not a session to be missed.

Don’t miss this chance to stay ahead of the curve with unmatched industry updates from discovery to commercialization and unlock comprehensive insights across a variety of cell types (αβ T, γδ T, NK, NKT, Macrophage, TIL, and more).